Trade Longeveron Inc. - LGVN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.62 |
| Open | 1.59 |
| 1-Year Change | 218% |
| Day's Range | 1.5 - 1.6 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 1.51 | -0.08 | -5.03% | 1.59 | 1.60 | 1.50 |
| Feb 20, 2025 | 1.62 | 0.00 | 0.00% | 1.62 | 1.68 | 1.59 |
| Feb 19, 2025 | 1.59 | 0.02 | 1.27% | 1.57 | 1.62 | 1.55 |
| Feb 18, 2025 | 1.55 | -0.23 | -12.92% | 1.78 | 1.82 | 1.52 |
| Feb 14, 2025 | 1.63 | 0.08 | 5.16% | 1.55 | 1.68 | 1.55 |
| Feb 13, 2025 | 1.52 | -0.03 | -1.94% | 1.55 | 1.55 | 1.49 |
| Feb 12, 2025 | 1.53 | 0.11 | 7.75% | 1.42 | 1.59 | 1.41 |
| Feb 11, 2025 | 1.43 | -0.05 | -3.38% | 1.48 | 1.48 | 1.40 |
| Feb 10, 2025 | 1.44 | -0.05 | -3.36% | 1.49 | 1.49 | 1.42 |
| Feb 7, 2025 | 1.49 | -0.09 | -5.70% | 1.58 | 1.67 | 1.46 |
| Feb 6, 2025 | 1.57 | 0.02 | 1.29% | 1.55 | 1.58 | 1.49 |
| Feb 5, 2025 | 1.50 | 0.05 | 3.45% | 1.45 | 1.54 | 1.44 |
| Feb 4, 2025 | 1.47 | 0.03 | 2.08% | 1.44 | 1.51 | 1.44 |
| Feb 3, 2025 | 1.44 | -0.05 | -3.36% | 1.49 | 1.49 | 1.35 |
| Jan 31, 2025 | 1.50 | -0.04 | -2.60% | 1.54 | 1.61 | 1.49 |
| Jan 30, 2025 | 1.56 | 0.02 | 1.30% | 1.54 | 1.60 | 1.54 |
| Jan 29, 2025 | 1.50 | -0.07 | -4.46% | 1.57 | 1.58 | 1.49 |
| Jan 28, 2025 | 1.59 | 0.03 | 1.92% | 1.56 | 1.59 | 1.53 |
| Jan 27, 2025 | 1.57 | -0.08 | -4.85% | 1.65 | 1.69 | 1.55 |
| Jan 24, 2025 | 1.66 | 0.04 | 2.47% | 1.62 | 1.69 | 1.62 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Longeveron Inc Company profile
Longeveron Inc. (LGVN) is a clinical-stage biotechnology company. Its lead drug component and cellular therapies address ageing and other life-threatening conditions. Founded in 2014, Longeveron is headquartered in Miami, US.
The biotech firm’s leading product Lomecel-B is derived from culture-expanded medicinal signalling cells (MSCs). The cells were sourced from young healthy adult donors’ - aged 18 to 45 - bone marrow to treat ageing-related diseases as they promote cell and tissue repair, organ maintenance and immune system function.
As of June 2022, the company is conducting Phase 2 clinical trials in hypoplastic left heart syndrome (HLHS) and Alzheimer’s disease. It has received orphan drug and rare paediatric disease designations from the US Food and Drug Administration (FDA).
Longeveron is also conducting Phase 1 and 2 clinical trials for ageing frailty, metabolic syndrome and acute respiratory distress syndrome due to Covid-19 or influenza.
Longeveron’s programmes have been awarded grant funding of more than $16.2m from various organisations, including the National Institute on Ageing (NIA), National Heart Lung and Blood Institute (NHLBI), the Alzheimer’s Association and the Maryland Stem Cell Research Fund (MSCRF).
Longeveron Inc. stock started trading on the NASDAQ stock exchange in February 2021 under the ticker symbol LGVN.
You can follow live LGVN stock price movements and price history and keep up with the latest LGVN share value at Capital.com
| Industry: | Biotechnology & Medical Research (NEC) |
1951 NW 7th Ave
Ste 520
MIAMI
FLORIDA 33136
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com